Seretide Accuhaler Inhaler - Fluticasone Propionate 100mcg, Salmeterol 50mcg

Seretide Accuhaler Inhaler

The Seretide Accuhaler Inhaler is a combination therapy designed for the management of asthma and chronic obstructive pulmonary disease (COPD). It combines Fluticasone Propionate, a glucocorticoid with anti-inflammatory properties, and Salmeterol, a long-acting beta-2 agonist that provides prolonged bronchodilation.

• Combination of Fluticasone Propionate 100mcg and Salmeterol 50mcg
• Designed for regular use to maintain control over asthma and COPD symptoms
• Inhalation device with a foil strip containing 60 doses

• Device Type Accuhaler
• Dose 50mcg Salmeterol and 100mcg Fluticasone Propionate per inhalation
• Pack Size 60 doses

Ideal for patients requiring regular treatment for asthma and COPD. Not suitable for immediate relief of asthma attacks.

Adults and adolescents aged 12 years and older with asthma or COPD.

GlaxoSmithKline is a leading pharmaceutical company known for its innovative respiratory products. The Seretide range is a testament to their commitment to providing effective solutions for respiratory health.